DrugCard
AI-powered pharmacovigilance platform for literature monitoring, regulatory intelligence, and adverse event management.
Paid Research
About DrugCard
DrugCard is an AI-powered pharmacovigilance platform and service provider for pharmaceutical companies, MAHs, CROs, and drug safety teams. Its core product automates global and local medical literature monitoring so pharmacovigilance teams can track PubMed full texts, local journals, and non-indexed sources in a standardized, audit-ready workflow. The platform is built to reduce manual screening, surface potentially relevant safety information, support AI article summaries and pre-assessment of safety relevance, translate local sources, and create literature cases with one click. Beyond literature screening, DrugCard offers regulatory intelligence software that aggregates updates from health authorities, plus an adverse event database for collecting, storing, importing, exporting, and processing safety data with ICH E2B(R2/R3) support. The company also provides pharmacovigilance services including local and global literature monitoring, ICSR/case processing, signal management, PSUR/DSUR and risk management documentation, LQPPV services, audits, training, and consultancy. DrugCard is best understood as a specialized B2B drug safety and compliance solution, not a general academic research search engine.
Key Features
✓Automated global and local medical literature monitoring
✓AI article summaries and safety-relevance pre-assessment
✓Coverage for PubMed, local journals, and non-indexed medical sources
✓One-click case creation from literature findings
✓Automatic translation of local literature sources
✓Regulatory intelligence feed for health authority updates
✓Adverse event database with ICH E2B(R2/R3) support
✓Audit-ready workflows with traceable screening documentation
Use Cases
Pharmaceutical pharmacovigilance teams automating literature screeningCROs managing local and global drug safety monitoring for clientsMAHs reducing compliance risk from missed safety publicationsDrug safety teams tracking regulatory authority updatesOrganizations managing adverse event intake, ICSR processing, and safety documentation
Pros & Cons
Pros
- ✓Purpose-built for pharmacovigilance and drug safety workflows
- ✓Combines platform automation with expert PV services
- ✓Supports local literature coverage, translation, and audit documentation
- ✓Includes regulatory intelligence and adverse event management capabilities
Cons
- ✗Specialized for regulated life-sciences teams rather than general researchers
- ✗Pricing and implementation details require contacting the company
- ✗May require onboarding to fit each organization's PV processes and source lists